Pancreatic Cancer Research

ResearcherChinese Academy of Medical Sciences & Peking Union Medical CollegeActive in the last 2 years

Hao Qin

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-1462-9868; OpenAlex author ID A5103918914. Sources: OpenAlex.

Their work

Papers
2 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2021: 1 paper · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 2

  1. Resveratrol: A promising agent in targeting senescent cancer-associated fibroblasts to inhibit pancreatic cancer progression. Co-author DOI 10.4251/wjgo.v17.i7.105034↗
  2. Blood small extracellular vesicles derived miRNAs to differentiate pancreatic ductal adenocarcinoma from chronic pancreatitis. First author DOI 10.1002/ctm2.520↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Suizhi Gao · 1 shared paper, 2021 · strength 0.10
  2. Bin Song · 1 shared paper, 2021 · strength 0.10
  3. Jiajia Xu · 1 shared paper, 2021 · strength 0.10
  4. Shiwei Guo · 1 shared paper, 2021 · strength 0.10
  5. Xiaohan Shi · 1 shared paper, 2021 · strength 0.10
  6. Zhuo Shao · 1 shared paper, 2021 · strength 0.10
  7. Gang Jin · 1 shared paper, 2021 · strength 0.10

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.